About Cambrex
What Cambrex is building
Funding rounds
Company type
Cambrex news and updates
Cambrex Corp. acquires Snapdragon Chemistry, Inc.
Cambrex, a global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services, has entered into a definitive agreement to acquire Snapdragon Chemistry, a U.S.-based provider of chemical process development services to a broad range of emerging and established biopharma customers.
Nov 21, 2022 | contractpharma.comCambrex Corp. increases headcount by 40
Cambrex is expected to add approximately 40 new jobs over the next 2-3 years at the new site in Minneapolis.
Oct 26, 2022 | topionetworks.comCambrex Corp. is developing methods of production
When faced with the challenge of combining three APIs — one incompatible with the others — into a FDC product, Cambrex had to develop new methods of production.
Oct 25, 2022 | pharmaceutical-technology.comCambrex Corp. expands facilities to Belgium
Cambrex will augment its Q1 Scientific storage service for the pharmaceutical and medical device industries with an expansion of its facility in Waterford, Ireland, and a new facility in Belgium.
Oct 8, 2022 | acs.orgCambrex Corp. expanded facilities to Waterford, Ireland on Oct 4th 22'.
Cambrex today announced the expansion of their stability storage business, Q1 Scientific, through adding 10,000 sq ft at their existing facility in Waterford, Ireland.
Oct 3, 2022 | irelandsoutheast.comCambrex Corp. invests into assets : molecule active pharmaceutical ingredient (API) manufacturing facility in the amount of $30M in High Point, North Carolina, United States
Cambrex has completed the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, NC.
Aug 31, 2022 | contractpharma.comAvondale Pharmaceuticals, LLC partnered with Cambrex Corp. on Mar 25th 22'.
BIRMINGHAM, Ala., March 25, 2022 /PRNewswire-PRWeb/ -- Avondale Pharmaceuticals, LLC, a specialty pharmaceutical company, announced today a product development partnership with Cambrex, a leading global contract development and manufacturing organization providing drug substance, drug product, and analytical services across the entire drug lifecycle.
Jan 1, 2022 | wfmz.comCambrex Corp. invests into assets : API manufacturing capabilities in the amount of $50M in Charles City, Iowa, United States
Cambrex announced the completion of a $50 million expansion of API manufacturing capabilities at its flagship Charles City, Iowa facility.
Jan 1, 2022 | europeanpharmaceuticalreview.comCambrex Corp. acquires Q1 Scientific Ltd.
Q1 Scientific, a Co Waterford-based provider of stability storage services for the pharma, medical device and life science industries, has been acquired by Cambrex, a US contract pharma company, for an undisclosed sum.
Jan 1, 2022 | irishtimes.comCambrex Corp. invests into assets : manufacturing facility in the amount of $30M in High Point, North Carolina, United States
Cambrex Corporation, a pharmaceutical manufacturer, will invest $30 million to expand its manufacturing facility in High Point, creating 78 new jobs.
Jan 1, 2022 | siteselectiongroup.comCambrex Corp. expanded facilities to Charles City, Iowa, United States on Apr 1st 19'.
Cambrex announced today the completion of a $50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing capabilities at its Charles City, Iowa facility.
Jan 1, 2021 | newswire.caKBC Belgium invests into Cambrex Corp.
Kbc Nv has invested 0.01% in Cambrex Corporation (NYSE:CBM).
Jan 1, 2019 | makdaily.comMorgan Stanley invests into Cambrex Corp.
Morgan Stanley has invested 0% in Cambrex Corporation (NYSE:CBM).
Jan 1, 2019 | whatsonthorold.com